11.11.25 -- OpenFold3 Redefining The Limits Of Protein Prediction Models

By transitioning to alternative solvents or leveraging process aids, the challenges associated with the use of these chemicals can be addressed, helping create a sustainable, greener footprint.

For many bioprocessing applications, artificial intelligence (AI) and machine learning (ML) can be used in every phase of development to support optimization and streamline repetitive, effort-intensive processes.

Cell therapies, using reprogrammed immune cells, offer treatments for diseases. Discover how LNPs enhance these therapies by delivering RNA for gene modulation and next-gen treatments.

See how Liquid Phase Peptide Synthesis (LPPS) uses traditional reactors to create more efficient and sustainable peptide manufacturing. Learn about key analytical and quality control considerations.

Traditional toxicity studies don’t always fit today’s complex drug modalities. Watch as experts discuss how we’re adapting small molecule IND-enabling studies to meet modern therapeutic challenges.

Review the optimization of the manufacturing process of a pharmaceutical intermediate, and uncover how yield can be improved substantially via suitable reaction engineering.

Accelerate drug discovery by leveraging transiently transfected assay-ready cells. This method improves assay sensitivity and reduces variability for GPCRs.

Characterizing the PROTAC hook effect is crucial for selecting candidates with enhanced cooperativity. Gain confidence with flexible, in-solution affinity measurements that reveal key biophysical parameters.

Gain expert insights into cell line development for biologics commercialization. and learn how CLD services—from DNA to GMP Master Cell Bank—can accelerate your path to clinical success.